We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Srs Labs, Inc. (MM) | NASDAQ:SRSL | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.33 | 0 | 01:00:00 |
FORM 4
[
X
]
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue.
See
Instruction 1(b).
|
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
OMB APPROVAL
OMB Number: 3235-0287 Estimated average burden hours per response... 0.5 |
|
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940 |
|
1. Name and Address of Reporting Person
*
DUKES DAVID R |
2. Issuer Name
and
Ticker or Trading Symbol
SRS LABS INC [ SRSL ] |
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
__ X __ Director _____ 10% Owner _____ Officer (give title below) _____ Other (specify below) |
C/O SRS LABS, INC., 2909 DAIMLER STREET |
3. Date of Earliest Transaction
(MM/DD/YYYY)
|
|
SANTA ANA, CA 92705 |
4. If Amendment, Date Original Filed
(MM/DD/YYYY)
|
6. Individual or Joint/Group Filing
(Check Applicable Line)
_ X _ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person |
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned |
||||||||||
1.Title of Security
(Instr. 3) |
2. Trans. Date | 2A. Deemed Execution Date, if any |
3. Trans. Code
(Instr. 8) |
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) |
6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) | 7. Nature of Indirect Beneficial Ownership (Instr. 4) | |||
Code | V | Amount | (A) or (D) | Price | ||||||
Common Stock | 7/20/2012 | D | 6416 | D | (1) | 0 | D |
Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities) |
|||||||||||||||
1. Title of Derivate Security
(Instr. 3) |
2. Conversion or Exercise Price of Derivative Security | 3. Trans. Date | 3A. Deemed Execution Date, if any |
4. Trans. Code
(Instr. 8) |
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) |
6. Date Exercisable and Expiration Date |
7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) |
8. Price of Derivative Security
(Instr. 5) |
9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) | 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) | 11. Nature of Indirect Beneficial Ownership (Instr. 4) | ||||
Code | V | (A) | (D) | Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||||||
Stock Option | $5.44 | 7/20/2012 | D | 10000 | 9/30/2003 | 9/30/2013 | Common Stock | 10000 | (2) | 0 | D | ||||
Stock Option | $5.44 | 7/20/2012 | D | 9000 | 9/30/2006 | 9/30/2013 | Common Stock | 9000 | (2) | 0 | D | ||||
Stock Option | $6.10 | 7/20/2012 | D | 30000 | 4/9/2008 | 4/9/2014 | Common Stock | 30000 | (2) | 0 | D | ||||
Stock Option | $5.49 | 7/20/2012 | D | 15000 | 6/30/2009 | 6/30/2014 | Common Stock | 15000 | (2) | 0 | D | ||||
Stock Option | $5.76 | 7/20/2012 | D | 30000 | 6/22/2009 | 6/22/2015 | Common Stock | 30000 | (2) | 0 | D | ||||
Stock Option | $5.15 | 7/20/2012 | D | 30000 | 6/22/2010 | 6/22/2016 | Common Stock | 30000 | (2) | 0 | D | ||||
Stock Option | $10.62 | 7/20/2012 | D | 15000 | 6/20/2010 | 6/20/2017 | Common Stock | 15000 | (2) | 0 | D | ||||
Stock Option | $10.62 | 7/20/2012 | D | 30000 | 6/20/2011 | 6/20/2017 | Common Stock | 30000 | (2) | 0 | D | ||||
Stock Option | $6.65 | 7/20/2012 | D | 25000 | 6/18/2012 | 6/18/2018 | Common Stock | 25000 | (2) | 0 | D | ||||
Stock Option | $6.25 | 7/20/2012 | D | 25000 | 7/20/2012 | 6/17/2019 | Common Stock | 25000 | (2) | 0 | D | ||||
Stock Option | $8.96 | 7/20/2012 | D | 25000 | 7/20/2012 | 6/20/2020 | Common Stock | 25000 | (2) | 0 | D | ||||
Stock Option | $8.96 | 7/20/2012 | D | 15000 | 7/20/2012 | 6/21/2020 | Common Stock | 15000 | (2) | 0 | D | ||||
Stock Option | $8.72 | 7/20/2012 | D | 25000 | 7/20/2012 | 6/19/2021 | Common Stock | 25000 | (2) | 0 | D |
Explanation of Responses: | |
( 1) | Disposed of pursuant to an Agreement and Plan of Merger and Reorganization (the "Merger Agreement"), dated as of April 16, 2012, by and among DTS, Inc. ("DTS"), DTS Merger Sub, Inc., DTS LLC and SRS Labs, Inc. ("SRS"). Pursuant to the terms of the Merger Agreement, SRS stockholders could elect to receive, in exchange for each share of SRS common stock held at the effective time of the Merger, either (i) $9.50 in cash, without interest and less any applicable withholding taxes or (ii) 0.31127 of a share of DTS common stock. |
( 2) | Pursuant to the Merger Agreement, each outstanding stock option to purchase shares of SRS common stock automatically became fully vested and exercisable immediately prior to the effective time of the Merger and, as of the effective time of the Merger, was cancelled in exchange for the right to receive a cash payment, without interest and less any applicable withholding taxes, equal to the product of the excess, if any, of (i) $9.50 over the exercise price of each such option and (ii) the number of shares of SRS common stock underlying such option. |
Reporting Owners
|
|||||
Reporting Owner Name / Address |
|
||||
Director | 10% Owner | Officer | Other | ||
DUKES DAVID R
C/O SRS LABS, INC. 2909 DAIMLER STREET SANTA ANA, CA 92705 |
X |
|
|
|
Signatures
|
||
/s/ David R. Dukes | 7/24/2012 | |
** Signature of Reporting Person |
Date
|
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | |
* | If the form is filed by more than one reporting person, see Instruction 4(b)(v). |
** | Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). |
Note: | File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. |
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number. |
1 Year Srs Labs Chart |
1 Month Srs Labs Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions